Common risk factors for heart failure and cancer

WC Meijers, RA de Boer - Cardiovascular research, 2019 - academic.oup.com
Cardiovascular (CV) disease and cancer are the leading causes of death., Over the last
decades, it has been appreciated that both CV disease and cancer are more common in …

Cancer and heart disease: associations and relations

RA de Boer, WC Meijers, P van der Meer… - European journal of …, 2019 - Wiley Online Library
Emerging evidence supports that cancer incidence is increased in patients with
cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from …

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …

RA de Boer, JS Hulot, CG Tocchetti… - European journal of …, 2020 - Wiley Online Library
The co‐occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …

Tofacitinib and risk of malignancy: results from the safety of tofacitinib in routine care patients with rheumatoid arthritis (STAR‐RA) study

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - Wiley Online Library
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …

Flaxseed lignans as important dietary polyphenols for cancer prevention and treatment: Chemistry, pharmacokinetics, and molecular targets

SF De Silva, J Alcorn - Pharmaceuticals, 2019 - mdpi.com
Cancer causes considerable morbidity and mortality across the world. Socioeconomic,
environmental, and lifestyle factors contribute to the increasing cancer prevalence …

The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology

F D'Ascenzi, F Anselmi, C Fiorentini… - European journal of …, 2021 - academic.oup.com
Cancer and cardiovascular diseases are the leading causes of death in high-income
countries. Cardiovascular complications can be found in cancer patients, being the result of …

[HTML][HTML] Carcinogenicity assessment: Addressing the challenges of cancer and chemicals in the environment

F Madia, A Worth, M Whelan, R Corvi - Environment international, 2019 - Elsevier
Cancer is a key public health concern, being the second leading cause of worldwide
morbidity and mortality after cardiovascular diseases. At the global level, cancer prevalence …

The role of response-shift in studies assessing quality of life outcomes among cancer patients: a systematic review

G Ilie, J Bradfield, L Moodie, T Lawen, A Ilie… - Frontiers in …, 2019 - frontiersin.org
Objective: Response-shift has been cited as an important measurement consideration when
assessing patient reported quality of life (QoL) outcomes over time among patients with …

The 'other'big complication: how chronic kidney disease impacts on cancer risks and outcomes

JS Lees, BMP Elyan, SM Herrmann… - Nephrology Dialysis …, 2023 - academic.oup.com
Cancer is the second leading cause of death in people with chronic kidney disease (CKD)
after cardiovascular disease. The incidence of CKD in patients with cancer is higher than in …

[HTML][HTML] Can physical activity eliminate the mortality risk associated with poor sleep? A 15-year follow-up of 341,248 MJ Cohort participants

LJ Chen, M Hamer, YJ Lai, BH Huang, PW Ku… - Journal of sport and …, 2022 - Elsevier
Background: This study examined the joint associations of sleep patterns and physical
activity with all-cause, cardiovascular disease (CVD), and cancer mortality. Methods: A total …